CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease Association Between Depressive Symptoms and Incident Cardiovascular Diseases The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis

Review ArticleApril 15, 2020

JOURNAL: Article Link

The Science Underlying COVID-19: Implications for the Cardiovascular System

PP Liu, A Blet, D Smyth et al. Keywords: COVID-19; pre-existing cardiovascular disease; ACE2 receptor; organ dysfunction;

Full Text PDF